JPH0432047B2 - - Google Patents
Info
- Publication number
- JPH0432047B2 JPH0432047B2 JP58051200A JP5120083A JPH0432047B2 JP H0432047 B2 JPH0432047 B2 JP H0432047B2 JP 58051200 A JP58051200 A JP 58051200A JP 5120083 A JP5120083 A JP 5120083A JP H0432047 B2 JPH0432047 B2 JP H0432047B2
- Authority
- JP
- Japan
- Prior art keywords
- caries
- myutans
- activity
- hinokitiol
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 claims description 30
- 208000002925 dental caries Diseases 0.000 claims description 23
- 239000000203 mixture Substances 0.000 claims description 21
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 claims description 15
- 229930007845 β-thujaplicin Natural products 0.000 claims description 15
- 230000000675 anti-caries Effects 0.000 claims description 10
- 239000003205 fragrance Substances 0.000 claims description 8
- 239000004480 active ingredient Substances 0.000 claims description 7
- 150000002596 lactones Chemical class 0.000 claims description 7
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 5
- GNKZMNRKLCTJAY-UHFFFAOYSA-N 4'-Methylacetophenone Chemical compound CC(=O)C1=CC=C(C)C=C1 GNKZMNRKLCTJAY-UHFFFAOYSA-N 0.000 claims description 4
- ZYEMGPIYFIJGTP-UHFFFAOYSA-N O-methyleugenol Chemical compound COC1=CC=C(CC=C)C=C1OC ZYEMGPIYFIJGTP-UHFFFAOYSA-N 0.000 claims description 4
- KSMVZQYAVGTKIV-UHFFFAOYSA-N decanal Chemical compound CCCCCCCCCC=O KSMVZQYAVGTKIV-UHFFFAOYSA-N 0.000 claims description 4
- GYCKQBWUSACYIF-UHFFFAOYSA-N Ethyl salicylate Chemical compound CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 claims description 2
- BJIOGJUNALELMI-ONEGZZNKSA-N Isoeugenol Natural products COC1=CC(\C=C\C)=CC=C1O BJIOGJUNALELMI-ONEGZZNKSA-N 0.000 claims description 2
- CDJJKTLOZJAGIZ-UHFFFAOYSA-N Tolylacetate Chemical compound CC(=O)OC1=CC=C(C)C=C1 CDJJKTLOZJAGIZ-UHFFFAOYSA-N 0.000 claims description 2
- BJIOGJUNALELMI-ARJAWSKDSA-N cis-isoeugenol Chemical compound COC1=CC(\C=C/C)=CC=C1O BJIOGJUNALELMI-ARJAWSKDSA-N 0.000 claims description 2
- 229940019836 cyclamen aldehyde Drugs 0.000 claims description 2
- 229940005667 ethyl salicylate Drugs 0.000 claims description 2
- 229940116837 methyleugenol Drugs 0.000 claims description 2
- PRHTXAOWJQTLBO-UHFFFAOYSA-N methyleugenol Natural products COC1=CC=C(C(C)=C)C=C1OC PRHTXAOWJQTLBO-UHFFFAOYSA-N 0.000 claims description 2
- SATCULPHIDQDRE-UHFFFAOYSA-N piperonal Chemical compound O=CC1=CC=C2OCOC2=C1 SATCULPHIDQDRE-UHFFFAOYSA-N 0.000 claims description 2
- BJIOGJUNALELMI-UHFFFAOYSA-N trans-isoeugenol Natural products COC1=CC(C=CC)=CC=C1O BJIOGJUNALELMI-UHFFFAOYSA-N 0.000 claims description 2
- ZFNVDHOSLNRHNN-UHFFFAOYSA-N xi-3-(4-Isopropylphenyl)-2-methylpropanal Chemical compound O=CC(C)CC1=CC=C(C(C)C)C=C1 ZFNVDHOSLNRHNN-UHFFFAOYSA-N 0.000 claims description 2
- 230000000694 effects Effects 0.000 description 28
- 230000002401 inhibitory effect Effects 0.000 description 16
- 241000894006 Bacteria Species 0.000 description 12
- 239000000341 volatile oil Substances 0.000 description 11
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 229930006000 Sucrose Natural products 0.000 description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 239000005720 sucrose Substances 0.000 description 6
- 239000002609 medium Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000008685 targeting Effects 0.000 description 5
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 229920001503 Glucan Polymers 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 239000002253 acid Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 235000015218 chewing gum Nutrition 0.000 description 2
- 229960003276 erythromycin Drugs 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- VVOAZFWZEDHOOU-UHFFFAOYSA-N magnolol Chemical compound OC1=CC=C(CC=C)C=C1C1=CC(CC=C)=CC=C1O VVOAZFWZEDHOOU-UHFFFAOYSA-N 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 208000002064 Dental Plaque Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 241001579869 Phazaca mutans Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- 241000194023 Streptococcus sanguinis Species 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000001013 cariogenic effect Effects 0.000 description 1
- 239000004075 cariostatic agent Substances 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000010639 cypress oil Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000008369 fruit flavor Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
Description
〔産業上の利用分野〕
この発明は、抗齲蝕性組成物、すなわち、齲蝕
を予防し、またはその進行を阻止するために用い
る組成物に関するものである。
〔従来の技術〕
近年、齲蝕、すなわち、虫歯の罹患率は著しく
増大しており、大きな社会問題にまで発展してい
る。一方、これに伴つて齲蝕の原因の研究も進ん
でおり、現在の定説では齲蝕の原因は食物中の蔗
糖が齲蝕原因菌の作用により変化を受け不溶性か
つ粘着性のグルカンを生成することにあるとされ
ている。このようにして生成されたグルカンによ
つて齲蝕原因菌が歯面に付着して増殖し歯垢を形
成する。そして、この歯垢をベースとしてその中
の細菌が糖醗酵により酸を発生し、その酸により
齲蝕が進行するのである。齲蝕の防止には歯の抵
抗性を高める方法、蔗糖を排除するか、蔗糖に代
わる甘味料を使用する方法、蔗糖により生成する
不溶性のグルカンを分解するかまたはグルカンの
生成を阻止する方法もしくは齲蝕原因菌を撲滅す
る方法等が考えられる。上記の方法はそれぞれ長
所欠点を備えているが、齲蝕の本質が齲蝕原因菌
による感染症であるため、この原因となる齲蝕原
因菌を撲滅することが齲蝕防止に最も効果的であ
ると考えられる。上記の菌としてはストレプトコ
ツカスミユータンス(Streptococcus Mutans)
やストレプトコツカスサングイス
(Streptococcus Sanguis)があげられる。齲蝕
防止のためにこのような齲蝕原因菌を駆遂しよう
とする試みはこれまでも数多くなされている。例
えば、ペニシリンやエリスロマイシン等の抗生物
質、齲蝕原因菌の細胞壁を溶解する細胞壁溶解酵
素やシクロヘキシジン等の殺菌剤の使用が試みら
れている。
〔発明が解決しようとする課題〕
しかしながら、これは口腔内および腸内細菌叢
の攪乱により自然の細菌バランスを壊し、しかも
副作用を惹起するという問題がある。このような
副作用の問題の解決がなされていないため広く用
いられるには到つていない。また、天然精油であ
るヒバ油の成分であるヒノキチオールを用いて上
記齲蝕原因菌を死滅させようとする試みもなされ
ているが、ヒノキチオールの抗齲蝕性にも限界が
あり、単独で用いた場合には比較的その抗齲蝕性
が短時間で失われてしまう。そのため、例えばチ
ユーインガムのように比較的長時間咀嚼するよう
なものに添加しても充分は齲蝕予防効果が期待で
きない。したがつて、目下のところ齲蝕防止のた
めに決定的な方法がないのが実情であり、食後、
歯ブラシで清掃するという物理的な方法に勝る予
防法の確立がなされていないのが現状である。
この発明は、このような事情に鑑みなされたも
ので、副作用が全くなくて安全性が高く、連用が
可能で、かつ齲蝕予防効果に優れた抗齲蝕性組成
物の提供をその目的とする。
〔課題を解決するための手段〕
上記の目的を達成するため、この発明の抗齲蝕
性組成物は、有効成分として、下記の(A)成分と(B)
成分とともに、(C)成分および(D)成分の少なくとも
一方が含有され、かつ上記(A)成分の含有量が全体
に対し0.01重量%以上に設定されているという構
成をとる。
(A) ヒノキチオール。
(B) クレジルアセテート、シクラメンアルデヒ
ド、イソオイゲノール、ヘリオトロピン、エチ
ルサルシレート、n−デカナール、p−メチル
アセトフエノンおよびメチルオイゲノールから
なる群から選ばれた少なくとも一つの合成香
料。
(C) C3〜C18のカルボン酸。
(D) C9〜C14のラクトン。
〔作用〕
すなわち、本発明者らは、ヒノキチオール自体
の有する優れた抗齲蝕性に着目し、その齲蝕予防
効果の向上を中心に一連の研究を重ねた。その結
果、ヒノキチオールを単独で使用するのではな
く、他の各種の化合物と組み合わせて使用する
と、組み合わせた化合物によつては、齲蝕予防効
果が増大することをつきとめた。そして、さらに
研究を重ねた結果、上記組み合わせる各種の化合
物のうち、特に特定のカルボン酸と特定のラクト
ンが効果の点で最も優れており、しかもこれに特
定の合成香料を組み合わせるとさらに効果が増大
することを見いだしこの発明に到達した。
このように、この発明は、副作用が全くなく安
全性の極めて高いヒノキチオールと、カルボン酸
と、ラクトンと、合成香料とを抗齲蝕性組成物の
有効成分として用いるところに最大の特徴があ
る。
つぎに、この発明を詳しく説明する。
天然精油や天然物質あるいは香料化合物ないし
はそれらの有効成分のある種のものには抗菌作用
があるという報告が散見されている。しかしなが
ら、最も強い齲蝕作用をもつミユータンス菌に対
する抗菌活性に関する報告は皆無である。そこで
本発明者らは、ヒノキチオールの抗菌作用の確認
に先立ち、まず第1段階として何らの抗菌作用が
報告されているか比較的汎用されている天然精油
を対象としミユータンス菌に対する抗菌活性を測
定した。抗菌活性は、それぞれ上記天然精油を5
%のアルコール溶液とし(これを供試成分とす
る)、これを、5%の蔗等を含有するハートイン
フユージヨン培地に、培地全体に対する天然精油
の割合が1/100〜1/1000(5%アルコール溶液
中の天然精油濃度が1/100〜1/1000)となる
ように添加し、培地が固化したのち、ミユータン
ス菌(ストレプトコツカスミユータンス
RIMD3125001)を穿刺接種して37℃で72時間以
上培養し、培地中、培地表面における菌の生育を
観察して測定した。抗ミユータンス菌活性がある
ものは後記の第1表のとおりである。抗ミユータ
ンス菌活性があるということは、天然精油を、培
地に対し1/1000の割合になるように添加し37℃
で72時間以上培養した場合においてミユータンス
菌の生育が認められないということである。そし
て、供試成分中の天然精油濃度をどんどん希釈し
てゆき、抗ミユータンス菌活性が認められる最小
濃度(有効生育阻止濃度)の逆数、例えば、天然
精油濃度が1/1000であるときは、その逆数の
1000を抗ミユータンス菌活性値として示した。対
象用として、厚朴エキス、厚朴エキスの有効成分
であるマグノロールならびにミユータンス菌に対
する殺菌作用をもつ抗生物質エリスロマイシンを
用い同様の実験を行つて第1表に併せて示した。
第1表に掲げる天然精油は、抗齲蝕用剤として知
られている厚朴エキス(特開昭57−85319号参照)
と同等にそれ以上の優れた抗ミユータンス菌活性
を示している。
このように、天然精油の有効成分が極めて抗ミ
ユータンス菌活性に富んでいることより、探索範
囲を合成香料およびカルボン酸、ラクトンのよう
な着香料の分野まで広げて抗ミユータンス菌活性
のある物質を調べた。その結果は後記の第2表の
とおりである。第2表に掲げる合成香料、カルボ
ン酸およびラクトン群が極めて高い抗ミユータン
ス菌活性を備えていた。
つぎに、ヒノキチオールを必須成分とし、これ
に上記第1表および第2表に示す成分を混合して
その抗ミユータンス菌活性とを調べた。その結果
を後記の第3表に示す。
[Industrial Application Field] This invention relates to an anti-caries composition, that is, a composition used to prevent caries or inhibit its progression. [Prior Art] In recent years, the prevalence of caries, that is, dental caries, has increased significantly and has developed into a major social problem. At the same time, research into the causes of caries is progressing, and the current theory is that the sucrose in food undergoes changes due to the action of caries-causing bacteria, producing insoluble and sticky glucans. It is said that Due to the glucan thus produced, caries-causing bacteria adhere to the tooth surface and multiply to form dental plaque. Using this plaque as a base, bacteria within it generate acid through sugar fermentation, and this acid causes dental caries to progress. To prevent caries, there are ways to increase tooth resistance, eliminate sucrose or use sweeteners instead of sucrose, break down the insoluble glucan produced by sucrose or prevent the production of glucan, or caries. Possible methods include eradicating the causative bacteria. Each of the above methods has advantages and disadvantages, but since caries is essentially an infection caused by caries-causing bacteria, eradicating the caries-causing bacteria is considered to be the most effective way to prevent caries. . The above bacteria include Streptococcus Mutans
and Streptococcus Sanguis. Many attempts have been made to eliminate such caries-causing bacteria in order to prevent caries. For example, attempts have been made to use antibiotics such as penicillin and erythromycin, cell wall lytic enzymes that dissolve the cell walls of caries-causing bacteria, and bactericidal agents such as cyclohexidine. [Problems to be Solved by the Invention] However, this method has the problem of disrupting the natural bacterial balance by disturbing the oral and intestinal flora, and causing side effects. Since the problem of such side effects has not been solved, it has not been widely used. In addition, attempts have been made to kill the caries-causing bacteria using hinokitiol, a component of the natural essential oil cypress oil, but the anti-caries properties of hinokitiol are also limited, and when used alone, loses its anti-caries properties relatively quickly. Therefore, even if it is added to something that is chewed for a relatively long time, such as chewing gum, a sufficient caries prevention effect cannot be expected. Therefore, the reality is that there is currently no definitive method for preventing dental caries.
Currently, no preventive method has been established that is superior to the physical method of cleaning with a toothbrush. The present invention was made in view of the above circumstances, and an object of the present invention is to provide an anti-caries composition that has no side effects, is highly safe, can be used repeatedly, and has an excellent caries preventive effect. [Means for Solving the Problem] In order to achieve the above object, the anti-caries composition of the present invention contains the following (A) component and (B) as active ingredients.
At least one of component (C) and component (D) is contained together with the components, and the content of component (A) is set to 0.01% by weight or more based on the total weight. (A) Hinokitiol. (B) At least one synthetic fragrance selected from the group consisting of cresyl acetate, cyclamenaldehyde, isoeugenol, heliotropin, ethyl salicylate, n-decanal, p-methylacetophenone, and methyleugenol. (C) C3 to C18 carboxylic acid. (D) C9 - C14 lactones. [Effect] Specifically, the present inventors focused on the excellent anti-caries properties of hinokitiol itself, and conducted a series of studies focusing on improving its caries-preventing effect. As a result, it was found that when hinokitiol is not used alone but in combination with various other compounds, the caries prevention effect increases depending on the combination of compounds. As a result of further research, it was found that among the various compounds mentioned above, a specific carboxylic acid and a specific lactone are the most effective in terms of effectiveness, and when they are combined with a specific synthetic fragrance, the effect is further increased. This invention was achieved by discovering the following. As described above, the greatest feature of this invention is that hinokitiol, which has no side effects and is extremely safe, carboxylic acid, lactone, and synthetic fragrance are used as the active ingredients of the anti-caries composition. Next, this invention will be explained in detail. There are reports that natural essential oils, natural substances, fragrance compounds, or certain of their active ingredients have antibacterial effects. However, there are no reports regarding antibacterial activity against Myutans bacteria, which has the strongest cariogenic effect. Therefore, prior to confirming the antibacterial effect of hinokitiol, the present inventors first measured the antibacterial activity against B. mutans using natural essential oils that have been reported to have any antibacterial effect or are relatively widely used. The antibacterial activity of each of the above natural essential oils is
% alcohol solution (this is used as the test component), and this is added to a heart infusion medium containing 5% moss etc., so that the ratio of natural essential oil to the entire medium is 1/100 to 1/1000 (5%). % alcohol solution so that the concentration of natural essential oil is 1/100 to 1/1000), and after the medium has solidified, add Streptococcus miutans.
RIMD3125001) was inoculated by puncture and cultured at 37°C for 72 hours or more, and the growth of the bacteria in the medium and on the surface of the medium was observed and measured. Those having anti-myutans activity are shown in Table 1 below. Anti-myutans activity means that natural essential oil is added to the culture medium at a ratio of 1/1000 and incubated at 37°C.
This means that no growth of M. myutans was observed when cultured for 72 hours or more. Then, the concentration of natural essential oil in the test component is gradually diluted, and the reciprocal of the minimum concentration (effective growth inhibitory concentration) at which antimyutans activity is observed, for example, when the concentration of natural essential oil is 1/1000, reciprocal
1000 was shown as the antimyutans activity value. Similar experiments were conducted using Atsuboku extract, Magnolol, which is an active ingredient of Atsubaku extract, and erythromycin, an antibiotic that has a bactericidal effect on B. myutans, and are shown in Table 1.
The natural essential oils listed in Table 1 are Koboku extract (see Japanese Patent Application Laid-Open No. 57-85319), which is known as an anti-caries agent.
shows superior antimyutans activity. In this way, since the active ingredients of natural essential oils are extremely rich in anti-myutans activity, we have expanded the scope of our search to the field of synthetic fragrances and flavoring agents such as carboxylic acids and lactones to find substances with anti-myutans activity. Examined. The results are shown in Table 2 below. The synthetic fragrances, carboxylic acids, and lactones listed in Table 2 had extremely high antimyutans activity. Next, hinokitiol was used as an essential component, and the components shown in Tables 1 and 2 above were mixed therewith to examine its antimyutans activity. The results are shown in Table 3 below.
【表】【table】
【表】【table】
【表】【table】
【表】【table】
【表】【table】
このように、この発明の抗齲蝕性組成物は、ヒ
ノキチオールと特定の合成香料と、特定のカルボ
ン酸および特定のラクトンの片方もしくは双方と
を有効成分とするものであつて、上記ヒノキチオ
ールを全体量に対し0.01重量%以上に設定し、こ
れと上記各成分とを組み合わせることにより、優
れた抗齲蝕効果が得られるため、うがい薬、トロ
ーチ、はみがき、チユーインガム等に最適であ
る。そして、その使用により従来の抗生物質のよ
うな副作用が全く生じないのであり、長期間の連
用に充分耐えうる極めて実用性の高いものであ
る。
つぎに、この発明を実施例にもとづき比較例と
対比して説明する。
ただし、以下の実施例では、ヒノキチオールと
他の成分との混用により優れた相乗効果が得られ
第3表の混合物を用いて行つた。
比較例 1
第3表に記載されたNo.1の混合物を対象とし、
これのミユータンス菌活性を求めたところ、ミユ
ータンス菌に対する有効生育阻止濃度は1/
10000(抗ミユータンス菌活性10000)であつた。
比較例 2
第3表のNo.2の混合物を対象とし、これのミユ
ータンス菌に対する有効生育阻止濃度を調べたと
ころその有効生育阻止濃度は1/8000(抗ミユー
タンス菌活性8000)であつた。
比較例 3
第3表のNo.3の混合物を対象とし、そのミユー
タンス菌に対する有効生育阻止濃度を求めた。こ
のものの有効生育阻止濃度は1/8000(抗ミユー
タンス菌活性8000)であつた。
比較例 4
第3表のNo.4の混合物を対象とし、この混合物
のミユータンス菌に対する有効生育阻止濃度を求
めた。その結果、有効生育阻止濃度は1/6000
(抗ミユータンス菌活性6000)であつた。
実施例 1
第3表のNo.5の混合物を対象とし、これのミユ
ータンス菌に対応する有効生育阻止濃度を求め
た。このものの有効生育阻止濃度は1/10000(抗
ミユータンス菌活性10000)であつた。この混合
物はスパイシー調の花の風味を有しており、この
ものの5%アルコール溶液を濃度10%の蔗糖溶液
に1/10000の割合で添加して口に含んでも違和
感および刺激は全く感じられなかつた。
比較例 5
第3表のNo.6の混合物を対象とし、そのミユー
タンス菌に対する有効生育阻止濃度を求めた。こ
のものの有効生育阻止濃度は1/8000(抗ミユー
タンス菌活性8000)であつた。
実施例 2
第3表のNo.7の混合物を対象とし、これのミユ
ータンス菌に対する有効生育阻止濃度を求めた。
このものの有効生育阻止濃度は1/9000(抗ミユ
ータンス菌活性9000)であつた。この混合物は、
No.3の脂肪酸臭の強いスパイシーな風味がマイル
ドになつてさわやかな残香を有しており、このも
のの5%アルコール溶液を濃度10%の蔗糖溶液に
1/10000の割合で添加して口に含んでもヒノキ
チオール等に起因する違和感および刺激は全く感
じられなかつた。
実施例 3
第3表のNo.8の混合物を対象とし、これのミユ
ータンス菌に対する有効生育阻止濃度を求めた。
このものの有効生育阻止濃度は1/7000(抗ミユ
ータンス菌活性7000)であつた。この混合物は、
No.4のスパイシーなフルーツの風味がマイルドに
なつてさわやかな残香を有しており、このものの
5%アルコール溶液を濃度10%の蔗糖溶液に1/
10000の割合で添加して口に含んでもヒノキチオ
ール等に起因する違和感および刺激は全く感じら
れなかつた。
As described above, the anti-caries composition of the present invention contains hinokitiol, a specific synthetic fragrance, and one or both of a specific carboxylic acid and a specific lactone as active ingredients, and the above-mentioned hinokitiol is contained in a total amount of By setting it at 0.01% by weight or more and combining it with the above-mentioned components, an excellent anti-caries effect can be obtained, making it ideal for gargles, troches, toothpastes, chewing gums, etc. Moreover, its use does not cause any side effects unlike those of conventional antibiotics, and it is highly practical as it can withstand long-term use. Next, the present invention will be explained based on examples and in comparison with comparative examples. However, in the following examples, excellent synergistic effects were obtained by mixing hinokitiol with other ingredients, and the mixtures shown in Table 3 were used. Comparative Example 1 Targeting the No. 1 mixture listed in Table 3,
When the activity of B. myutans was determined, the effective growth-inhibiting concentration against B. myutans was 1/
10,000 (antimyutans activity 10,000). Comparative Example 2 The effective growth-inhibiting concentration against B. myutans was investigated using the mixture No. 2 in Table 3, and the effective growth-inhibiting concentration was found to be 1/8000 (anti-Myutans activity: 8000). Comparative Example 3 Using the mixture No. 3 in Table 3, its effective growth-inhibiting concentration against P. myutans was determined. The effective growth-inhibiting concentration of this product was 1/8000 (anti-Myutans activity 8000). Comparative Example 4 Targeting the mixture No. 4 in Table 3, the effective growth-inhibiting concentration of this mixture against B. myutans was determined. As a result, the effective growth inhibitory concentration was 1/6000
(Anti-myutans activity 6000). Example 1 Targeting the mixture No. 5 in Table 3, the effective growth-inhibiting concentration corresponding to P. myutans was determined. The effective growth-inhibiting concentration of this product was 1/10,000 (anti-myutans activity 10,000). This mixture has a spicy floral flavor, and even if you add a 5% alcohol solution of this mixture to a 10% sucrose solution at a ratio of 1/10,000 and put it in your mouth, you will not feel any discomfort or irritation at all. Ta. Comparative Example 5 Using the mixture No. 6 in Table 3, its effective growth-inhibiting concentration against P. myutans was determined. The effective growth-inhibiting concentration of this product was 1/8000 (anti-Myutans activity 8000). Example 2 Targeting the mixture No. 7 in Table 3, the effective growth-inhibiting concentration against B. myutans was determined.
The effective growth-inhibiting concentration of this product was 1/9000 (anti-Myutans activity 9000). This mixture is
The spicy flavor with a strong fatty acid odor of No. 3 becomes milder and has a refreshing aftertaste.A 5% alcohol solution of No. 3 is added to a 10% sucrose solution at a ratio of 1/10,000 and tasted. Even when containing hinokitiol, no discomfort or irritation caused by hinokitiol or the like was felt at all. Example 3 Targeting the mixture No. 8 in Table 3, the effective growth-inhibiting concentration against B. myutans was determined.
The effective growth-inhibiting concentration of this product was 1/7000 (anti-myutans activity 7000). This mixture is
The spicy fruit flavor of No. 4 becomes milder and has a refreshing lingering aroma.
Even when it was added at a ratio of 10,000% and taken into the mouth, no discomfort or irritation caused by hinokitiol or the like was felt at all.
Claims (1)
もに、(C)成分および(D)成分の少なくとも一方が含
有され、かつ上記(A)成分の含有量が全体に対し
0.01重量%以上に設定されていることを特徴とす
る抗齲蝕性組成物。 (A) ヒノキチオール。 (B) クレジルアセテート、シクラメンアルデヒ
ド、イソオイゲノール、ヘリオトロピン、エチ
ルサルシレート、n−デカナール、p−メチル
アセトフエノンおよびメチルオイゲノールから
なる群から選ばれた少なくとも一つの合成香
料。 (C) C3〜C18のカルボン酸。 (D) C9〜C14のラクトン。[Claims] 1. At least one of the following components (A) and (B) as well as components (C) and (D) is contained as active ingredients, and the content of the above (A) component is for the whole
An anti-caries composition characterized by having a caries content of 0.01% by weight or more. (A) Hinokitiol. (B) At least one synthetic fragrance selected from the group consisting of cresyl acetate, cyclamenaldehyde, isoeugenol, heliotropin, ethyl salicylate, n-decanal, p-methylacetophenone, and methyleugenol. (C) C3 to C18 carboxylic acid. (D) C9 - C14 lactones.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5120083A JPS59175422A (en) | 1983-03-26 | 1983-03-26 | Cariostatic agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5120083A JPS59175422A (en) | 1983-03-26 | 1983-03-26 | Cariostatic agent |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS59175422A JPS59175422A (en) | 1984-10-04 |
JPH0432047B2 true JPH0432047B2 (en) | 1992-05-28 |
Family
ID=12880247
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5120083A Granted JPS59175422A (en) | 1983-03-26 | 1983-03-26 | Cariostatic agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS59175422A (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0816049B2 (en) * | 1986-09-09 | 1996-02-21 | ライオン株式会社 | Oral composition for deodorizing tobacco tar |
US5330771A (en) * | 1992-10-29 | 1994-07-19 | Wm. Wrigley Jr. Company | Use of eugenol in chewing gum as an antioxidant |
EP0854702B1 (en) * | 1995-10-11 | 2005-01-26 | Warner-Lambert Company LLC | Antimicrobial compositions containing a c 3-c 6 alcohol |
US6042812A (en) * | 1996-11-26 | 2000-03-28 | The Procter & Gamble Company | Flavor systems for oral care products |
US7595065B2 (en) | 2002-06-25 | 2009-09-29 | Wm. Wrigley Jr. Company | Breath freshening and oral cleansing products with synergistic combinations of magnolia bark extract and essential oils |
US7632525B2 (en) | 2002-06-25 | 2009-12-15 | Wm. Wrigley Jr. Company | Breath freshening and oral cleansing product with magnolia bark extract in combination with surface active agents |
CN1723011A (en) | 2002-06-25 | 2006-01-18 | Wm·雷格利Jr·公司 | Breath freshening and oral cleansing product with magnolia bark extract |
US7544377B2 (en) | 2005-12-02 | 2009-06-09 | Gic Innovations Company | Chewable compositions with fast release magnolia bark extract |
US7592025B2 (en) | 2005-12-02 | 2009-09-22 | Gic Innovations Company | Vehicles for oral care with magnolia bark extract |
CA2631501A1 (en) | 2005-12-02 | 2007-06-07 | Gic Innovations Company | Confectionary compositions with magnolia bark extract |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS503378A (en) * | 1973-05-11 | 1975-01-14 | ||
JPS54129136A (en) * | 1978-03-30 | 1979-10-06 | Yamanouchi Pharmaceut Co Ltd | Anti-dental plaque agent |
JPS55120509A (en) * | 1979-03-08 | 1980-09-17 | Sunstar Inc | Oral cavity agent composition blended with crude drug |
JPS5829618A (en) * | 1981-08-18 | 1983-02-21 | Dainippon Printing Co Ltd | Method of joining molded ring to brim of paper cup |
JPS5929619A (en) * | 1982-08-11 | 1984-02-16 | T Hasegawa Co Ltd | Preventing agent for carious tooth |
-
1983
- 1983-03-26 JP JP5120083A patent/JPS59175422A/en active Granted
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS503378A (en) * | 1973-05-11 | 1975-01-14 | ||
JPS54129136A (en) * | 1978-03-30 | 1979-10-06 | Yamanouchi Pharmaceut Co Ltd | Anti-dental plaque agent |
JPS55120509A (en) * | 1979-03-08 | 1980-09-17 | Sunstar Inc | Oral cavity agent composition blended with crude drug |
JPS5829618A (en) * | 1981-08-18 | 1983-02-21 | Dainippon Printing Co Ltd | Method of joining molded ring to brim of paper cup |
JPS5929619A (en) * | 1982-08-11 | 1984-02-16 | T Hasegawa Co Ltd | Preventing agent for carious tooth |
Also Published As
Publication number | Publication date |
---|---|
JPS59175422A (en) | 1984-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3877537B2 (en) | Antibacterial agent for oral composition and oral composition containing the same | |
JPH0140005B2 (en) | ||
WO2011055707A1 (en) | Dentifrice composition | |
JP5493731B2 (en) | Dentifrice composition | |
JPH0432047B2 (en) | ||
JP3614479B2 (en) | Periodontal disease-causing bacteria or caries-causing bacteria inhibitor, oral composition and food containing them | |
KR20200012181A (en) | Toothpaste composition comprising herbal extract mixture as effective component | |
JP6016342B2 (en) | Oral composition | |
JPH03255031A (en) | Periodontosis preventing composition | |
JP2021020869A (en) | Oral indigenous bacteria growth promoter, and oral composition | |
JPH0639375B2 (en) | Anti-caries agent | |
US4060602A (en) | Oral preparations for preventing dental caries | |
JP2017081831A (en) | Antimicrobial agent for oral cavities, and oral composition | |
JP3009531B2 (en) | Periodontal disease prevention agent | |
JP6631223B2 (en) | Oral antibacterial agent and oral composition | |
WO2021079921A1 (en) | Growth inhibitor for pathogenic bacteria in oral cavity, oral microflora improver, and composition for oral cavity | |
JPH0567608B2 (en) | ||
JPH0320364B2 (en) | ||
JP7362417B2 (en) | Growth inhibitors, oral compositions, and promoters of oral pathogenic bacteria | |
JP2010047512A (en) | Oral composition | |
KR0158048B1 (en) | Tooth brushing components for mouth sanitary using bacteriosin | |
KR102123325B1 (en) | Oil composition for preventing and improving periodontal disease | |
KR102123321B1 (en) | Oil composition for spherical cleaning | |
JP6921655B2 (en) | Protease inhibitors, biofilm formation inhibitors, and oral compositions | |
US4590215A (en) | Growth inhibitor for cariogenic bacteria |